| Evidence for a Role of the Lumenal M3-M4 Loop in Skeletal Muscle Ca Release Channel (Ryanodine Receptor) Activity and Conductance Biophysical Journal, Volume 79, Issue 2, 1 August 2000, Pages 828-840 Ling Gao, David Balshaw, Le Xu, Ashutosh Tripathy, Chunlin Xin and Gerhard Meissner Abstract We tested the hypothesis that part of the lumenal amino acid segment between the two most C-terminal membrane segments of the skeletal muscle ryanodine receptor (RyR1) is important for channel activity and conductance. Eleven mutants were generated and expressed in HEK293 cells focusing on amino acid residue I4897 homologous to the selectivity filter of K channels and six other residues in the M3-M4 lumenal loop. Mutations of amino acids not absolutely conserved in RyRs and IPRs (D4903A and D4907A) showed cellular Ca release in response to caffeine, Ca-dependent [H]ryanodine binding, and single-channel K and Ca conductances not significantly different from wild-type RyR1. Mutants with an I4897 to A, L, or V or D4917 to A substitution showed a decreased single-channel conductance, loss of high-affinity [H]ryanodine binding and regulation by Ca, and an altered caffeine-induced Ca release in intact cells. Mutant channels with amino acid residue substitutions that are identical in the RyR and IPR families (D4899A, D4899R, and R4913E) exhibited a decreased K conductance and showed a loss of high-affinity [H]ryanodine binding and loss of single-channel pharmacology but maintained their response to caffeine in a cellular assay. Two mutations (G4894A and D4899N) were able to maintain pharmacological regulation both in intact cells and in vitro but had lower single-channel K and Ca conductances than the wild-type channel. The results support the hypothesis that amino acid residues in the lumenal loop region between the two most C-terminal membrane segments constitute a part of the ion-conducting pore of RyR1. Abstract | Full Text | PDF (1716 kb) |
| RyR1/RyR3 Chimeras Reveal that Multiple Domains of RyR1 Are Involved in Skeletal-Type E-C Coupling Biophysical Journal, Volume 84, Issue 4, 1 April 2003, Pages 2655-2663 Claudio F. Perez, Andrew Voss, Isaac N. Pessah and Paul D. Allen Abstract Skeletal-type E-C coupling is thought to require a direct interaction between RyR1 and the -DHPR. Most available evidence suggests that the cytoplasmic II–III loop of the dihydropyridine receptor (DHPR) is the primary source of the orthograde signal. However, identification of the region(s) of RyR1 involved in bidirectional signaling with the -DHPR remains elusive. To identify these regions we have designed a series of chimeric RyR cDNAs in which different segments of RyR1 were inserted into the corresponding region of RyR3 and expressed in dyspedic 1B5 myotubes. RyR3 provides a preferable background than RyR2 for defining domains essential for E-C coupling because it possesses less sequence homology to RyR1 than the RyR2 backbone used in previous studies. Our data show that two regions of RyR1 (chimera Ch-10 aa 1681–2641 and Ch-9 aa 2642–3770), were independently able to restore skeletal-type E-C coupling to RyR3. These two regions were further mapped and the critical RyR1 residues were 1924–2446 (Ch-21) and 2644–3223 (Ch-19). These results both support and refine the previous hypothesis that multiple domains of RyR1 combine to functionally interact with the DHPR during E-C coupling. Abstract | Full Text | PDF (255 kb) |
| Skeletal and Cardiac Ryanodine Receptors Exhibit Different Responses to Ca Overload and Luminal Ca Biophysical Journal, Volume 92, Issue 8, 15 April 2007, Pages 2757-2770 Huihui Kong, Ruiwu Wang, Wenqian Chen, Lin Zhang, Keyun Chen, Yakhin Shimoni, Henry J. Duff and S. R. Wayne Chen Abstract Spontaneous Ca release occurs in cardiac cells during sarcoplasmic reticulum Ca overload, a process we refer to as store-overload-induced Ca release (SOICR). Unlike cardiac cells, skeletal muscle cells exhibit little SOICR activity. The molecular basis of this difference is not well defined. In this study, we investigated the SOICR properties of HEK293 cells expressing RyR1 or RyR2. We found that HEK293 cells expressing RyR2 exhibited robust SOICR activity, whereas no SOICR activity was observed in HEK293 cells expressing RyR1. However, in the presence of low concentrations of caffeine, SOICR could be triggered in these RyR1-expressing cells. At the single-channel level, we showed that RyR2 is much more sensitive to luminal Ca than RyR1. To identify the molecular determinants responsible for these differences, we constructed two chimeras between RyR1 and RyR2, N-RyR1(1–4006)/C-RyR2(3962–4968) and N-RyR2(1–3961)/C-RyR1(4007–5037). We found that replacing the C-terminal region of RyR1 with the corresponding region of RyR2 (N-RyR1/C-RyR2) dramatically enhanced the propensity for SOICR and the response to luminal Ca, whereas replacing the C-terminal region of RyR2 with the corresponding region of RyR1 (N-RyR2/C-RyR1) reduced the propensity for SOICR and the luminal Ca response. These observations indicate that the C-terminal region of RyR is a critical determinant of both SOICR and the response to luminal Ca. These chimeric studies also reveal that the N-terminal region of RyR plays an important role in regulating SOICR and luminal Ca response. Taken together, our results demonstrate that RyR1 differs markedly from RyR2 with respect to their responses to Ca overload and luminal Ca, and suggest that the lack of spontaneous Ca release in skeletal muscle cells is, in part, attributable to the unique intrinsic properties of RyR1. Abstract | Full Text | PDF (1142 kb) |
Copyright © 1999 The Biophysical Society. All rights reserved.
Biophysical Journal, Volume 77, Issue 2, 808-816, 1 August 1999
doi:10.1016/S0006-3495(99)76933-X
Channels, Receptors, and Transporters
Manjunatha B. Bhat*, Salim M. Hayek*, Jiying Zhao*, Weijin Zang#, Hiroshi Takeshima§, W. Gil Wier# and Jianjie Ma*,
, 
* Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio 44106 USA
# Department of Physiology, University of Maryland, Baltimore, Maryland 21201 USA
§ Department of Pharmacology, University of Tokyo, Tokyo 113, Japan
Address reprint requests to Dr. Jianjie Ma, Department of Physiology and Biophysics, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106. Tel.: 216-368-2684; Fax: 216-368-5586.In cardiac muscle, excitation-contraction (E-C) coupling involves entry of extracellular Ca2+ through voltage-sensitive Ca2+ channels, which in turn triggers release of Ca2+ from the sarcoplasmic reticulum (SR), via a Ca2+-induced Ca2+ release (CICR) mechanism. This phenomenon is mediated by ryanodine receptor (RyR) which functions as Ca2+ release channel (Fleischer and Inui, 1989,McPherson and Campbell, 1993,Sutko and Airey, 1996). RyR is a single polypeptide of ∼560 kDa, and exists in a homotetrameric structure with at least two functional domains: a carboxyl-terminal hydrophobic domain containing the conduction pore of the Ca2+ release channel (Takeshima et al,Zorzato et al,Bhat et al), and a large amino-terminal cytoplasmic domain referred to as the “foot structure” (Block et al,Lai et al,Sorrentino and Volpe, 1993,Franzini-Armstrong and Jorgensen, 1994). The cardiac (RyR2) and skeletal (RyR1) Ca2+ release channels are encoded by different genes, and share a high degree (∼66%) of amino acid sequence identity, especially in the carboxyl-terminal region, which contains several putative transmembrane segments (Takeshima et al,Zorzato et al,Nakai et al,Otsu et al,Wagenknecht et al,Takeshima, 1993). The carboxyl-terminal region of the protein also contains putative binding site(s) for Ca2+ and ryanodine (Callaway et al,Witcher et al). In recent studies, we have successfully used a heterologous expression system to study the structure-function relationship of the skeletal Ca2+ release channel (Bhat et al–c). Full-length RyR1 expressed in Chinese hamster ovary (CHO) cells exhibits single channel properties similar to those of RyR from skeletal muscle SR. The carboxyl-terminal ∼20% of the RyR1 (RyR-C) was found to contain structures sufficient to form a functional Ca2+ release channel (Bhat et al). The amino-terminal foot structure appears to participate in the ion-conduction, Ca2+-dependent regulation, and caffeine-induced activation of the Ca2+ release channel (Bhat et al–c).
Compared with RyR1, it has been difficult to study the structure-function relationship of RyR2. First, the cDNA for RyR2 is intrinsically unstable, which frequently undergoes large deletions and/or recombination during its propagation in Escherichia coli strains making the DNA preparation difficult. Second, it is not easy to select stable mammalian cell clones expressing RyR2 proteins. Nakai et al expressed and indirectly studied the function of the RyR2 channel in Xenopus oocytes by measuring Ca2+-dependent chloride current in response to stimulation with caffeine. Caffeine-induced Ca2+ release as well as Ca2+-dependent [3H]ryanodine binding were studied by Imagawa et al in CHO cells expressing RyR2. But, no single channel studies with expressed RyR2 have been reported thus far. In the present study, we have successfully overcome the problem of RyR2 cDNA instability in E. coli cells and expressed the full-length RyR2 protein in CHO cells. The Ca2+ release channel activity of the expressed RyR2 was studied using single channel current measurements and by intracellular Ca2+ imaging in single cells using laser scanning confocal microscopy. The single channel properties of RyR2 expressed in CHO cells were similar to those of native Ca2+ release channels from the rabbit cardiac muscle SR. RyR2 channels expressed in CHO cells were found to exhibit multiple conductance states more frequently than the native Ca2+ release channels from the cardiac muscle SR. Caffeine, an exogenous activator of RyR, induced release of [Ca2+]i from cells expressing RyR2. Confocal imaging of single CHO cells expressing RyR2 did not detect any spontaneous or caffeine-induced local Ca2+ release events (viz., “Ca2+ sparks”) typically seen in cardiac muscle cells.
The entire cDNA sequence (∼16.5kb) of the rabbit cardiac muscle RyR was cloned into the pHRRS1 expression vector and the transcription occurs under the control of the SV40 promoter (Nakai et al). This DNA was transformed into a competent HB101 strain of E. coli cells and grown in LB medium at 30°C. The bacteria were harvested for DNA isolation mid-to-late in the logarithmic period of growth. CHO cells were grown at 37°C and 5% CO2 in Ham's F-12 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100μg/ml streptomycin. The expression plasmids were introduced into the cells (60–70% confluent) using lipofectAmine reagent (Life Technologies, Inc., Gaithersburg, MD) following manufacturer's instructions, or by electroporation methods (Imagawa et al). Stable transfectant cells were selected with G418 (0.5mg/ml, Calbiochem, La Jolla, CA) ∼48h after transfection. The level of RyR2 protein expression was tested using Western blot analysis.
Control and transfected CHO cells were harvested and washed twice with ice-cold PBS and lysed with ice-cold modified RIPA buffer (150mM NaCl, 50mM Tris-Cl, pH 8.0, 1mM EGTA, 1% Triton X-100, 1% sodium deoxycholate) in the presence of protease inhibitors (0.5mM Pefabloc, 1μM pepstatin, 1μM leupeptin, 1μg/ml aprotinin, and 1mM benzamidine). The proteins in the whole cell lysate were mixed with the 2X sample buffer (200mM Tris-Cl, pH 6.7, 9% SDS, 6% β-mercaptoethanol, 15% glycerol, 0.01% bromophenol blue) and separated on a 3–12% linear gradient SDS-PAGE gel after heating the samples at 37°C for ∼15min. The proteins were then transferred to a polyvinylidene difluoride (PVDF) membrane and blotted with C3-33 monoclonal antibody raised against the RyR2 protein (Affinity BioReagents, Golden, CO), and horseradish peroxidase-linked secondary antibody. The proteins were visualized using the enhanced chemiluminescence detection system (Amersham Corp., Piscataway, NJ).
Single rat cardiac ventricular cells were obtained from two-month-old Sprague-Dawley rats by an enzymatic technique described in detail previously (Lopez-Lopez et al). Both cardiac myocytes and CHO cells expressing RyR2 were loaded with the Ca2+ indicator Fluo-3 by incubation for 30min or longer in Tyrode's solution to which 10μM Fluo-3 AM was added (Molecular Probes Inc., Eugene, OR). Recordings of [Ca2+] were made in normal Tyrode's solution (composition in mM: NaCl, 140; dextrose, 10; Hepes, 10; KCl, 4.0; MgCl2, 1; CaCl2, 1; pH adjusted to 7.3–7.4 with NaOH) at room temperature, as described (Bhat et al). For “x-y” or “full-frame” imaging of calcium in the CHO cells a Bio-Rad MRC 600 confocal microscope (Bio-Rad Laboratories, Inc., Hercules, CA) was used. Fluo-3 fluorescence line-scan images were acquired with the homemade confocal microscope attached to the camera port of a Nikon Diaphot inverted microscope equipped with a 60× plan-apo oil-immersion objective (numerical aperture 1.4), with a resolution of 3ms per scan line (Parker et al). The fluorescence is expressed as normalized increases in fluorescence compared to “resting” level (F/F0).
Junctional SR membranes were isolated from rabbit cardiac muscle following the procedure similar to that used to prepare the skeletal muscle SR membranes (Ma et al). Briefly, cardiac muscle tissues were homogenized in 100mM NaCl, 2mM EDTA, 0.1mM EGTA, and 5mM Tris-Maleate (pH 6.8). Microsome vesicles obtained after sequential centrifugation at 2600×g and 35,000×g were loaded onto discontinuous sucrose gradients. The junctional SR membranes were recovered from the 40–45% region of the gradients. The junctional SR membrane vesicles were stored at −75°C at a concentration of 3–5mg protein/ml; 1–3μl of the vesicles were used for recording of single channel currents in the lipid bilayer.
Microsomal membrane vesicles were isolated from transfected CHO cells as described (Bhat et al). Briefly, the cells were homogenized on ice in hypotonic lysis buffer (10mM Hepes-Tris, pH 7.4, 1mM EDTA) containing protease inhibitors (0.5mM Pefabloc-SC, 1μM pepstatin, 1μM leupeptin, 1μg/ml aprotinin, and 1mM benzamidine) using nitrogen cavitation (300 Psi for 15min on ice) and with 10 strokes in a tight-fitting Dounce homogenizer, followed by 15 strokes after addition of an equal volume of sucrose buffer (500mM sucrose, 10mM Hepes-Tris, pH 7.4, 1mM EDTA). Microsome vesicles were collected by centrifugation of post-nuclear supernatant (10,000×g, 15min) at 100,000×g for 45min at 4°C. The pellet was resuspended in a buffer containing 250mM sucrose, 10mM Hepes-Tris, pH 7.2. The membrane vesicles were stored at a protein concentration of 2–6mg/ml at −75°C until use. Usually, 1–3μl of microsomal membrane vesicles was used for reconstitution of Ca2+ release channels in the lipid bilayer system.
Lipid bilayer membranes were formed across an aperture of ∼200μm diameter using the Muller-Rudin method with a mixture of phosphatidylethanolamine/phosphatidylserine/cholesterol (6:6:1); the lipids were dissolved in decane at a concentration of 40mg/ml. Incorporation of the Ca2+ release channel in bilayer was achieved by addition of membrane vesicles containing RyR2 proteins to the cis solution, under a concentration gradient of 200mM (cis)/50mM (trans) cesium gluconate. After incorporation of a single Ca2+ release channel, the concentration of cesium gluconate in the trans solution was adjusted to 200mM. The pH in both cis and trans solutions was maintained throughout the experiment at 7.4 with 10mM Hepes-Tris. The free Ca2+ concentration in both solutions was buffered with 1mM EGTA, and measured using a Ca2+-sensitive electrode (Orion, Boston, MA). Orientation of the Ca2+ release channel in the lipid bilayer, usually in the cis-cytoplasmic trans-luminal SR manner, was determined by the sensitivity of the channel to cytoplasmic Ca2+ (Bhat et al). To maintain stability of the bilayer membrane and channel activity, designed pulse protocols were used to measure currents through the single Ca2+ release channels. The bilayer membrane was kept at a holding potential of 0mV, and pulsed to different test potentials of 0.5–1-s durations. Single channel currents were recorded with an Axopatch 200A patch clamp unit (Axon Instruments, Inc., Foster City, CA). Data acquisition and pulse generation were performed with a 486 computer and 1200 Digidata A/D-D/A convertor (Axon Instruments). The currents were sampled at 0.05 ms/point and filtered at 1kHz through an 8-pole Bessel filter. Single channel data analyses were performed with the pClamp program.
The expression vector pHRRS1 contains the cDNA sequence (∼16.5kb) encoding the full-length RyR2 protein. One of the commonly encountered difficulties in working with large DNA molecules such as pHRRS1 (total size ∼24kb) is their tendency to be unstable in that the cDNA undergoes spontaneous deletions and/or rearrangements during plasmid propagation. This phenomenon appears to be specific for RyR2 cDNA since we encountered no such problems with the RyR1 cDNA (Bhat et al–c). We have optimized the procedure to overcome this problem and to stabilize the DNA sequence by growing the host bacterial strain (HB101) at a lower temperature (30°C) and by harvesting the cells for plasmid DNA isolation before the culture grows to saturation. Of the several bacterial strains tested (such as DH5α, JM109, SURE, HB101), we found HB101 to be efficient for stable propagation of RyR2 cDNA. A similar technique has been used to reduce the probability of instability of retroviral DNA clones that are otherwise unstable (Kanahan et al,Joshi and Jeang, 1993).
CHO cells were transfected with pHRRS1 using the cationic lipid lipofectAmine as described by the manufacturer, or using electroporation as described (Imagawa et al). Transfected cells were isolated ∼48h after transfection, and the expression of RyR2 protein was assayed by Western blot analysis (Fig. 1). CHO cells transfected with pHRRS1 expressed a protein of high Mr (∼560 kDa, lane 7) that is identical to RyR2 from rabbit cardiac muscle SR (lane 4). These proteins were detected with a monoclonal antibody (C3-33) raised against canine cardiac ryanodine receptor, and this antibody also recognizes RyR1 from skeletal muscle SR as well as that expressed in CHO cells (lanes 2 and 3). No protein was recognized by the C3-33 antibody in untransfected CHO cells (lane 1), indicating that CHO cells do not contain any detectable levels of endogenous RyR1 and RyR2.
To isolate stable clones expressing RyR2, CHO cells expressing RyR2 were cultured by limiting dilution in media containing G418 (0.5mg/ml). Of the 28 clones analyzed, two (clones C-26 and C-53) were found to express proteins of significantly lower molecular mass than the native RyR2 (Fig. 1, lane 4) or RyR2 transiently expressed in CHO cells (lane 7), and both these proteins were recognized by the monoclonal antibody C3-33 (Fig. 1, lanes 5 and 6). This suggests that the RyR2 cDNA has undergone deletions and/or rearrangements in these stable CHO clones, similar to its instability in bacterial host cells as described above. This result raises the need for caution in the expression of functional RyR2 proteins in heterologous systems. While the reason for this phenomenon is not clearly understood, in this study we have used transiently transfected CHO cells expressing only the high molecular weight (∼560K) RyR2 for functional analysis.
The function of RyR2 expressed in CHO cells was studied by measuring the changes in intracellular Ca2+ ([Ca2+]i) in response to stimulation with caffeine, which is an activator of the Ca2+ release channel (Fig. 2). Application of 10mM caffeine to CHO cells expressing RyR2 resulted in an increase of [Ca2+]i in a reversible manner in two of the four cells shown in Figure 2A (cells 1 and 2). No changes in [Ca2+]i were observed in untransfected CHO cells (not shown). The absence of caffeine response in cells 3 and 4 in Figure 2A is likely due to the lack of RyR2 expression in these cells. The ability of caffeine to induce Ca2+ release suggests that RyR2 expressed in CHO cells is capable of functioning as Ca2+ release channels (Imagawa et al).
The Ca2+ release channel functions of native and expressed RyR2 were further studied by using the lipid bilayer reconstitution system. Functional channel activity could be measured by incorporating the microsomal membrane vesicles from CHO cells expressing RyR2 into lipid bilayer using cesium gluconate as current carrier (Bhat et al). The single channel currents through expressed RyR2 exhibited fast kinetics of transition between open and closed states (Fig. 3). These properties are comparable to those of the native RyR2 Ca2+ release channel currents recorded using SR membrane vesicles from rabbit cardiac muscle (see Figure 4A). The RyR2 channels are activated by micromolar concentrations of [Ca2+] in the cis (cytoplasmic) solution. As shown in Figure 3B, chelation of [Ca2+] in the cytoplasmic solution from 220μM to 240 nM and 80 nM gradually decreased the channel open probability (Po=21.47±3.48%, 220μM; Po=1.60±0.36%, 240 nM; Po=0.70±0.10%, 80 nM), leading to complete inhibition of the channel activity at [Ca2+]=32 nM. This is similar to the Ca2+-dependent activation of recombinant RyR1 channels expressed in CHO cells (Bhat et al–c). Furthermore, the channels formed by the expressed RyR2 are sensitive to modification by ryanodine in that the channel conductance is reduced by ∼50% and the open lifetime of the channels is increased dramatically (Fig. 3A, bottom four traces). Open-time histogram analyses of native and expressed RyR2 channels revealed two similar time constants, i.e., τ01=0.65ms and 0.44ms, and τ02=2.63ms and 2.19ms for native and expressed RyR2 channels, respectively (Figure 4B).
We have previously described the functional properties of RyR1 expressed in CHO cells (Bhat et al–c). Comparison of the single channel properties of full-length RyR1 and RyR2 expressed in CHO cells is illustrated in Fig. 5. Both RyR1 and RyR2 channels exhibit distinct subconductance states (O1 through O4). However, the RyR2 expressed in CHO cells stays open more frequently at lower conductance levels (i.e., O1 and O3) with rare transitions to half and full conductance levels (i.e., O2 and O4) (Figure 5A). This is in contrast to RyR1 channels expressed in CHO cells, which mostly open to full conductance state (i.e., O4) when activated (Figure 5B). The O4 state occurs in the majority of the experiments with the RyR1 channels (∼63%, 30 of 48 experiments), whereas O3 is the major conductance state occurring with the RyR2 channels (∼80%, 23 of 29 experiments), with only brief transitions to the O4 state. The mean variance analysis of the amplitude histogram for RyR2 channels expressed in CHO cells is presented in Fig. 6, which illustrates the presence of a major peak corresponding to the O3 state with minor peaks at O1 and O4 states (Ma and Zhao, 1994). At +50mV, the RyR2 channels exhibit a mean outward (cytoplasm → lumen) current amplitude of 14.90±0.68 pA (n=24), which corresponds to the O3 conductance level. By contrast, the major outward current amplitude for RyR1 was 20.23±1.29 pA (n=48, Bhat et al), which corresponds to the O4 conductance level, and this is similar to the native RyR1 channels from rabbit skeletal muscle SR (Bhat et al). The analysis of the current-voltage relationship of the RyR2 channels is presented in Fig. 7. Under the recording conditions of symmetrical 200mM cesium gluconate, three distinct conductance states could be measured (O1=∼100 pS, O3=∼290 pS, and O4=∼401 pS) (Fig. 7).
, and
of the open conductance states, and C represents the closed state. The algorithm for mean variance analysis was written by Dr. Stephen W. Jones.The difference in the distribution of the conductance states between RyR2 and RyR1 may reflect the differences in the pore properties of these channels. This may happen because of the differences in the channel structure itself and/or differential interaction with the regulatory proteins. While the RyR1 channel opens to the full conductance state in >60% of the experiments, the RyR2 channel exhibits full conductance state in only <20% of the experiments. Furthermore, the RyR2 channels appear to be unstable, as they always exhibit frequent transitions to subconductance states of O1 and O3 (see Figure 5A). Subconductance states are characteristic features of the Ca2+ release channels from both skeletal and cardiac muscles, which likely reflect the oligomeric structure of the RyR protein complex, although the molecular mechanism(s) is largely unknown. FK506 binding proteins (FKBP) have been shown to associate and regulate the function of the Ca2+ release channels (Marks, 1996). While FKBP12 specifically associates with RyR1, RyR2 preferentially interacts with FKBP12.6 (Jayaraman et al,Timerman et al,Timerman et al). These proteins are known to regulate the function of RyRs by stabilizing the conductance state(s) of the Ca2+ release channels (Brillantes et al,Ma et al,Ahern et al), and the RyR channels depleted of FKBP12 have been shown to exhibit subconductance states (Ahern et al,Shou et al). While we do not know whether CHO cells express any endogenous FKBP12 or FKBP12.6, it will be interesting to examine the properties of RyR2 channels in CHO cells co-transfected with these regulatory proteins.
In cardiac muscle cells, spontaneous local increases in intracellular Ca2+, termed Ca2+ sparks, have been observed which occur spontaneously (Fig. 8A top, panel a; Cheng et al), and in response to activation of voltage-gated Ca2+ channels (Cannell et al,Cannell et al,Lopez-Lopez et al,Lopez-Lopez et al). Stimulation of cardiac myocytes with caffeine increases the frequency of Ca2+ sparks (Fig. 8A top, panel b) leading up to a global increase in the intracellular Ca2+ (Fig. 8A top, panel c). Similar elementary Ca2+ release events, although smaller in size than the cardiac Ca2+ sparks, have also been recorded in skeletal muscle cells (Tsugorka et al). However, it is not known whether a single or a group of Ca2+ release channels acting in concert constitute the “Ca2+ release units” underlying the local Ca2+ transients in muscle cells. We tested for the presence of spontaneous changes in intracellular Ca2+ in CHO cells expressing RyR2 (Figure 8B). Under resting conditions (Fig. 8B top, panel a), or in response to stimulation with caffeine (Fig. 8B top, panel b) no spontaneous local Ca2+ transients were evident in the line-scan images of CHO cells expressing RyR2, although caffeine was capable of inducing Ca2+ release in these cells (Fig. 8B top, panel c, and bottom).
The lack of local Ca2+ transients in CHO cells expressing RyR2 is similar to our recent results where CHO cells expressing RyR1 also did not exhibit spontaneous or caffeine-activated signals typical of Ca2+ sparks (Bhat et al). These results suggest that ryanodine receptors by themselves are not sufficient to support elementary Ca2+ release events, although they are capable of functioning as Ca2+ release channels both in vivo (caffeine-induced Ca2+ release, Fig. 2) and in vitro (single channel experiments, Figure 3 and Figure 4 and Figure 5). The absence of muscle-specific spatial environment in CHO cells may not support local cooperative opening of expressed Ca2+ release channels which is believed to be responsible for the origin of Ca2+ sparks. The absence in heterologous expression systems of muscle-specific accessory protein(s) (as discussed above) that interact with RyR to constitute a “local Ca2+ release unit” may also contribute to the lack of spontaneous or caffeine-induced Ca2+ sparks in CHO cells. The activity of both skeletal and cardiac Ca2+ release channels is controlled by both cytoplasmic and luminal Ca2+ (Sitsapesan and Williams, 1997). Furthermore, in cardiac myocytes the fractional SR Ca2+ release and the frequency and amplitude of Ca 2+ sparks are increased by an increase in the SR Ca2+ content (Bassani et al,Lukyanenko et al). Although the Ca2+ content of the intracellular stores of CHO cells is not known, it may not mimic that of muscle cells to support spontaneous opening of the expressed RyR channels.
We thank Dr. Stephen W. Jones for his generous help with the mean variance analysis.
This work was supported by an American Heart Association (Northeast Ohio Affiliate) post-doctoral fellowship (to M.B.B.), an Established Investigatorship from the American Heart Association (to J.M.), and National Institutes of Health Grant AG15556 (to J.M.).
Ahern et al., 1997 (1997). Subconductance states in single-channel activity of skeletal muscle ryanodine receptors after removal of FKBP12. Biophys. J. 72, 146–162. Abstract | | CrossRef | PubMed
Bassani et al., 1995 (1995). Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am. J. Physiol. 268, C1313–C1319. PubMed
Bhat et al., 1997a (1997). Deletion of amino acids 1641–2437 from the foot region of skeletal muscle ryanodine receptor alters the conduction properties of the Ca release channel. Biophys. J. 73, 1320–1328. Abstract | | CrossRef | PubMed
Bhat et al., 1997b (1997). Functional calcium release channel formed by the carboxyl-terminal portion of ryanodine receptor. Biophys. J. 73, 1329–1336. Abstract | | CrossRef | PubMed
Bhat et al., 1997c (1997). Caffeine-induced release of intracellular Ca from Chinese hamster ovary cells expressing skeletal muscle ryanodine receptor. Effect on full-length and carboxyl-terminal portion of calcium release channel. J. Gen. Physiol. 101, 749–762. PubMed
Block et al., 1988 (1988). Structural evidence for a direct interaction between the molecular components of the transverse tubule/sarcoplasmic reticulum junction in skeletal muscle. J. Cell Biol. 107, 2587–2600. CrossRef | PubMed
Brillantes et al., 1994 (1994). Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 77, 513–523. Abstract | | CrossRef | PubMed
Callaway et al., 1994 (1994). Localization of the high and low affinity [3H]-ryanodine binding sites on the skeletal muscle Ca2+ release channel. J. Biol. Chem. 269, 15876–15884. PubMed
Cannell et al., 1994 (1994). Spatial non-uniformities in [Ca2+]i during excitation-contraction coupling in cardiac myocytes. Biophys. J. 67, 1942–1956. Abstract | | CrossRef | PubMed
Cannell et al., 1995 (1995). The control of calcium release in heart muscle. Science 268, 1045–1049. PubMed
Cheng et al., 1993 (1993). Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 262, 740–744. PubMed
Fleischer and Inui, 1989 (1989). Biochemistry and biophysics of excitation-contraction coupling. Annu. Rev. Biophys. Biophys. Chem. 18, 333–364. PubMed
Franzini-Armstrong and Jorgensen, 1994 (1994). Structure and development of E-C coupling units in skeletal muscle. Annu. Rev. Physiol. 56, 509–534. PubMed
Imagawa et al., 1992 (1992). Expression of Ca2+-induced Ca2+ release channel activity from cardiac ryanodine receptor cDNA in Chinese hamster ovary cells. J. Biochem. 112, 508–513. PubMed
Jayaraman et al., 1992 (1992). FK506 binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem. 267, 9474–9477. PubMed
Joshi and Jeang, 1993 (1993). Reduction in growth temperature minimizes instability of large plasmids containing HIV-1 proviral genomes. Biotechniques 14, 883–886. PubMed
Kanahan et al., 1991 (1991). Plasmid transformation of Escherichia coli and other bacteria. Methods Enzymol. 204, 63–113. CrossRef | PubMed
Lai et al., 1989 (1989). The ryanodine receptor-Ca2+ release channel complex of skeletal muscle sarcoplasmic reticulum. Evidence for a cooperatively coupled, negatively charged homotetramer. J. Biol. Chem. 264, 16776–16785. PubMed
Lopez-Lopez et al., 1994 (1994). Local stochastic release of Ca2+ in voltage-clamped rat heart cells: visualization with confocal microscopy. J. Physiol. (Lond) 480, 21–29. PubMed
Lopez-Lopez et al., 1995 (1995). Local calcium transients triggered by single L-type calcium channel currents in cardiac cells. Science 268, 1042–1045. PubMed
Lukyanenko et al., 1996 (1996). Regulation of calcium release by calcium inside the sarcoplasmic reticulum in ventricular myocytes. Pfluegers Arch. 432, 1047–1054. PubMed
Ma et al., 1995 (1995). Rectification of skeletal muscle ryanodine receptor mediated by FK506 binding protein. Biophys. J. 69, 2398–2404. Abstract | | CrossRef | PubMed
Ma and Zhao, 1994 (1994). Highly cooperative and hysteretic response of the skeletal muscle ryanodine receptor to changes in proton concentrations. Biophys. J. 67, 626–633. Abstract | | CrossRef | PubMed
Marks, 1996 (1996). Cellular functions of immunophilins. Physiol. Rev. 76, 631–649. PubMed
McPherson and Campbell, 1993 (1993). The ryanodine receptor/Ca2+ release channel. J. Biol. Chem. 268, 13765–13768. PubMed
Nakai et al., 1990 (1990). Primary structure and functional expression from cDNA of the cardiac ryanodine receptor/calcium release channel. FEBS Lett. 271, 169–177. CrossRef | PubMed
Otsu et al., 1990 (1990). Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J. Biol. Chem. 265, 13472–13483. PubMed
Parker et al., 1997 (1997). A high-resolution, confocal laser scanning microscope and flash photolysis system for physiological studies. Cell Calcium 21, 441–452. CrossRef | PubMed
Shou et al., 1998 (1998). Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature 391, 489–492. CrossRef | PubMed
Sitsapesan and Williams, 1997 (1997). Regulation of current flow through ryanodine receptors by luminal Ca2+J. Membr. Biol. 159, 179–185. PubMed
Sorrentino and Volpe, 1993 (1993). Ryanodine receptors: how many, where and why?. Trends Pharmacol. Sci. 14, 98–103. Abstract | | CrossRef | PubMed
Sutko and Airey, 1996 (1996). Ryanodine receptor Ca2+ release channels: does diversity in form equal diversity in function?. Physiol. Rev. 76, 1027–1071. PubMed
Takeshima, 1993 (1993). Primary structure and expression from cDNAs of the ryanodine receptor. Ann. N.Y. Acad. Sci. 707, 165–177. CrossRef | PubMed
Takeshima et al., 1989 (1989). Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 339, 439–445. CrossRef | PubMed
Timerman et al., 1994 (1994). The ryanodine receptor from canine heart sarcoplasmic reticulum is associated with a novel FK-506 binding protein. Biochem. Biophys. Res. Commun. 198, 701–706. CrossRef | PubMed
Timerman et al., 1996 (1996). Selective binding of FKBP12.6 by the cardiac ryanodine receptor. J. Biol. Chem. 271, 20385–20391. CrossRef | PubMed
Tsugorka et al., 1995 (1995). Imaging elementary events of calcium release in skeletal muscle cells. Science 269, 1723–1726. PubMed
Wagenknecht et al., 1989 (1989). Three dimensional architecture of the calcium channel/foot structure of sarcoplasmic reticulum. Nature 338, 167–170. CrossRef | PubMed
Witcher et al., 1994 (1994). Photoaffinity labeling of the ryanodine receptor/Ca2+ release channel with an azido derivative of ryanodine. J. Biol. Chem. 269, 13076–13079. PubMed
Zorzato et al., 1990 (1990). Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 265, 2244–2256. PubMed